# synthetic_trial_amd

An emulated target trial comparing I) the bevacizumab arm (n 65) of the ABC trial --- a prospective, double-masked, multicentre randomised controlled trial undertaken in the United Kingdom during 2006–08 --- with II) a synthetic arm from 31,151 eyes receiving aflibercept during routine care across 27 sites in England during 2012–18.

![Study design](/figs/fig_1_readme.png)

# Table of contents

- [Heading](#heading)
  * [Sub-heading](#sub-heading)
    + [Sub-sub-heading](#sub-sub-heading)
- [Heading](#heading-1)
  * [Sub-heading](#sub-heading-1)
    + [Sub-sub-heading](#sub-sub-heading-1)
- [Heading](#heading-2)
  * [Sub-heading](#sub-heading-2)
    + [Sub-sub-heading](#sub-sub-heading-2)

<!-- toc -->

# Arms
## Bevacizumav trial arm (ABC trial)

## Aflibercept synthetic arm (Electronic Health Records)

# Quasi-randomsiation

# Analyses
## Noninferiority

## Superiority

## Time-to-event

create bash script that runs scripts as pipeline in sequence